Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in Interest ReceivablesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

60 Degrees Pharmaceuticals (SXTPW) Net Cash Flow (2022 - 2025)

Historic Net Cash Flow for 60 Degrees Pharmaceuticals (SXTPW) over the last 4 years, with Q3 2025 value amounting to $2.1 million.

  • 60 Degrees Pharmaceuticals' Net Cash Flow rose 2469.42% to $2.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $808516.0, marking a year-over-year decrease of 2115.74%. This contributed to the annual value of -$483631.0 for FY2024, which is 12663.51% down from last year.
  • Per 60 Degrees Pharmaceuticals' latest filing, its Net Cash Flow stood at $2.1 million for Q3 2025, which was up 2469.42% from -$1.5 million recorded in Q2 2025.
  • Over the past 5 years, 60 Degrees Pharmaceuticals' Net Cash Flow peaked at $2.2 million during Q3 2023, and registered a low of -$1.6 million during Q4 2024.
  • In the last 4 years, 60 Degrees Pharmaceuticals' Net Cash Flow had a median value of -$130230.0 in 2023 and averaged $252392.5.
  • Per our database at Business Quant, 60 Degrees Pharmaceuticals' Net Cash Flow skyrocketed by 81657.11% in 2023 and then tumbled by 1240958.38% in 2024.
  • Over the past 4 years, 60 Degrees Pharmaceuticals' Net Cash Flow (Quarter) stood at -$193251.0 in 2022, then soared by 32.61% to -$130230.0 in 2023, then crashed by 1158.81% to -$1.6 million in 2024, then skyrocketed by 231.0% to $2.1 million in 2025.
  • Its Net Cash Flow was $2.1 million in Q3 2025, compared to -$1.5 million in Q2 2025 and $1.8 million in Q1 2025.